糖尿病へのクリティカルパスの応用

書誌事項

タイトル別名
  • An application of critical path to type 2 diabetes mellitus
  • トウニョウビョウ エ ノ クリティカルパス ノ オウヨウ

この論文をさがす

抄録

To clarify the benefit of critical path to diabetic patients, blood glucose control critical path for two weeks was made and length of stay, plan achievement rate, discharge standard achievement rate and glycohemoglobin Alc levels (on admission, on 6 months and 12 months after discharge) were examined by comparison to those in non-path group. There was no significant difference in the number of patients, age. The length of stay in path group (17.1±5.5 days) was significantly shorter than that for non-path group (26.6± 6.4 days) (p<0.001). However, the plan achievement rate in path group (36.5±48.1%) was significantly lower than that in non-path group (56.5±49.7%) (p<0.001). There was no significant difference in a plan achievement rate between both groups. As the length of stay variance, it was 265 patient factors (delays of recovery 174, lack of understanding 91), staff factors 33, hospital factors 8 and social factors 2. As for the discharge standard achievement variance, it was recognized 11 cases in a patient factor entirely. Glycohemoglobin Alclevels in path group and non-path group were 8.97±2.24% and 9.35±1.96% on admission, 6.89±1.00% and 7.07±0.82% on 6 months after discharge, and 6.77±0.98% and 7.00±0.78% on 12 months after discharge, respectively and there was no significant difference between two groups. Glycohemoglobin A1c levels in each group were timedependently decreased until 12 months after discharge.

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ